LISATA THERAPEUTICS, INC. — Director's Dealing 2012

Jan 13, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2012-01-12

Reporting Person: Wei Eric (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-01-12	Common Stock, par value $0.001 per share	G	120000	—	Acquired	22529874	Indirect

Footnotes

F1: On January 12, 2012, Mr. Wei transferred 120,000 shares of common stock, par value $0.001 per share, of NeoStem, Inc. (the "Company"), owned directly by Mr. Wei to RimAsia Capital Partners, L.P., a Cayman Islands exempted limited partnership ("RimAsia LP") for no consideration.

F2: These securities are held by RimAsia LP. RimAsia Capital Partners GP, L.P., a Cayman Islands exempted limited partnership ("RimAsia GP"), is the general partner of RimAsia LP. RimAsia Capital Partners GP, Ltd., a Cayman Islands exempted company ("RimAsia Ltd."), is the general partner of RimAsia GP. Mr. Wei is the managing partner of RimAsia LP, an indirect partner of RimAsia GP and a director of RimAsia Ltd. As a result, Mr. Wei may be deemed to have sole power to vote certain of the securities held by RimAsia LP. Mr. Wei disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.